首页|雷帕霉素对γδT细胞体外增殖和细胞毒活性的影响

雷帕霉素对γδT细胞体外增殖和细胞毒活性的影响

扫码查看
目的 探讨雷帕霉素与Torin2对人γδT细胞体外培养增殖和细胞毒活性的影响及相关机制。方法 选择10例健康志愿者,其中男性5例,女性5例;平均年龄68。0岁(标准差4。7岁)。选择人慢性淋巴细胞白血病(CLL)肿瘤细胞株MEC-1。从志愿者外周静脉血获得外周血单个核细胞(PBMC),经处理获得γδT细胞。体外增殖培养的人γδT细胞在第10天观察细胞形态特征,流式细胞术检测人γδT细胞百分率。γδT细胞分别用100nmol/L雷帕霉素(雷帕霉素组)和Troin2处理(Troin2组),同时用RPMI 1640培养液作为空白对照(对照组),分别培养24、48 h,计算活细胞数。采用不同效靶比(1∶1、3∶1、9∶1、18∶1、36∶1),乳酸脱氢酶(LDH)释放法检测人γδT细胞对MEC-1细胞的杀伤作用。流式细胞术检测各组白细胞介素(IL)-17的表达。Western blot检测磷脂酰肌醇3-激酶(PI3K)、丝苏氨酸激酶(AKT)、磷酸化AKT(p-AKT)、哺乳动物雷帕霉素靶蛋白(mTOR)、磷酸化mTOR(p-mTOR)、起始因子4E结合蛋白1(4EBP-1)的表达。结果 扩增前人γδT细胞百分含量为4。70%±1。17%,经10 d扩增且纯化后γδT细胞百分含量为94。20%±2。18%。雷帕霉素组24 h扩增倍数为1。45±0。20,48 h扩增倍数为2。71±0。06,与对照组间差异无统计学意义(P>0。05);Torin2组24 h扩增倍数为1。14±0。05,48 h扩增倍数为2。09±0。06,均显著低于雷帕霉素组及对照组(P<0。05)。雷帕霉素组γδT细胞的杀伤活性分别为 0。05%±0。01%(1∶1)、10。84%±0。88%(3∶1)、23。02%±0。65%(9∶1)、50。74%±2。96%(18∶1)、77。75%±0。55%(36∶1),均显著高于对照组(P<0。05);Torin2组γδT细胞的杀伤活性分别为0。06%±0。01%(1∶1)、4。06%±0。84%(3∶1)、10。72%±2。97%(9∶1)、18。20%±2。83%(18∶1)、36。18%±2。19%(36∶1),均低于雷帕霉素组及对照组(P<0。05)。雷帕霉素组IL-17表达为(32。7±1。7)%,Troin2组IL-17表达为(12。2±1。4)%,均显著低于对照组(73。1±2。7)%(均P<0。05)。且Troin2组抑制γδT分泌IL-17程度更明显,差异有统计学意义(P<0。05)。Western blot结果显示,与对照组相比,雷帕霉素组、Troin2组mTOR表达水平均下降,差异有统计学意义(t 雷帕霉素组=14。23,P<0。05;tTroin2组=11。67,P<0。05);雷帕霉素组、Troin2组p-mTOR表达水平均下降,差异有统计学意义(t雷帕霉素组=16。78,P<0。05;tTroin2组=25。31,P<0。05);雷帕霉素组PI3K表达提高,差异有统计学意义(t=18。77,P<0。05);AKT表达提高,差异有统计学意义(t=22。21,P<0。05);p-AKT表达提高,差异有统计学意义(=19。33,P<0。05);4EBP-1表达提高,差异有统计学意义(t=14。37,P<0。05)。结论 雷帕霉素能在不影响体外人γδT细胞增殖的基础上,增强人γδT细胞对MEC-1细胞的肿瘤杀伤活性并抑制其IL-17的水平,其机制可能与mTOR C1/C2位点之间的负反馈机制相关。
Effects of Rapamycin on proliferation and cytotoxicity of γδT cells in vitro
Objective To investigate the effects of Rapamycin and Torin2 on the proliferation and cytotoxicity of human γδT cells in vitro and the related mechanisms.Methods A total of 10 healthy volunteers were enrolled,which included 5 males and 5 females with mean age of 68.0 years old(standard deviation 4.7 years old).The human chronic lymphocytic leukemia(CLL)tumor cell line MEC-1 was selected,the peripheral blood mononuclear cells(PBMC)were obtained from peripheral ve-nous blood of volunteers,and γδT cells were obtained after treatment.The morphological characteristics of human γδT cells cultured in vitro were observed on the 10th day,and the percentage of human γδT cells was detected by flow cytometry.TheγδT cells were treated with 100 nmol/L Rapamycin(Rapamycin group)and Troin2(Troin2 group),respectively,and RPM1 1640 culture medium was used as blank control(control group).The cells were cultured for 24-hour and 48-hour,and live cell counts was calculated.The killing effect of human γδT cells on MEC-1 cells was detected by lactate dehydrogenase(LDH)re-lease method with different effector-target ratios(1∶1,3∶1,9∶1,18∶1,36∶1).The expression of interleukin(IL)-17 in each group was detected by flow cytometry,and Western blot was used to detect the expression of phosphatidylinositol 3-kinase(PI3K),serine threonine kinase(AKT),phosphorylated AKT(p-AKT),mammalian rapamycin target protein(mTOR),phosphorylated mTOR(p-mTOR)and initiation factor 4E binding protein 1(4EBP-1)protein.Results The percentage of γδT cells was 4.70%±1.17%,and the percentage of γδT cells was 94.20%±2.18%after 10-day amplification and purification.In Rapamycin group,the 24-hour amplification factor was 1.45±0.2,and 48-hour amplification factor was 2.71±0.06,and there was no significant difference between Rapamycin group and control group(P>0.05).The amplification folds of Torin2 group at 24-hour and 48-hour were 1.14± 0.05 and 2.09±0.06,respectively,which were significantly lower than those of Rapamycin group and control group(P<0.05).The killing activity of γδT cells in Rapamycin group were 0.05%±0.01%(1∶1),10.84%±0.88%(3∶1),23.02%±0.65%(9∶1),50.74%±2.96%(18∶1)and 77.75%±0.55%(36∶1),respectively,which were significantly higher than those in control group(P<0.05).The killing activity of γδT cells in Torin2 group was 0.06%±0.01%(1∶1),4.06%±0.84%(3∶1),10.72%±2.97%(9∶1),18.20%±2.83%(18∶1)and 36.18%±2.19%(36∶1),respectively,which were lower than those in Rapamycin group and con-trol group(P<0.05).The expression of IL-17 in Rapamycin group(32.7±1.7)%and Troin2 group(12.2±1.4)%was significant-ly lower than that in control group(73.1±2.7)%(P<0.05).The inhibition of IL-17 secretion by γδT in Troin2 group was more ob-vious,and the difference was statistically significant.Western blot results showed that compared with control group,the expression of mTOR in Rapamycin group and Troin2 group decreased,and the difference was statistically significant(tRapamycin group=14.23,P<0.05;tTroin2 group=11.67,P<0.05).The expression level of p-mTOR in Rapamycin group and Troin2 group decreased,and the difference was statistically significant(tRapamyin group=16.78,P<0.05;tTroin2 group=25.31,P<0.05);the expression of PI3K in Ra-pamycin group was increased,and the difference was statistically significant(t=18.77,P<0.05);the expression of AKT was in creased,and the difference was statistically significant(t=22.21,P<0.05);the expression of p-AKT was increased,and the difference was statistically significant(t=19.33,P<0.05);the expression of 4EBP-1 was increased,and the difference was statis-tically significant(t=14.37,P<0.05).Conclusion It is demonstrated that Rapamycin could enhance the tumor killing activity of human γδT cells on MEC-1 cells and inhibit the level of IL-17 un-affecting the proliferation of human γδT cells in vitro,and mechanism may be related to the negative feedback mechanism between mTOR C1/C2 sites.

RapamycinγδT cellsMEC-1mTORinterleukin-17(IL-17)cell proliferationcellular activitycytotoxic activity

曾雪娇、张瑞、谢仁古丽·阿力木、曲建华

展开 >

新疆医科大学 第一附属医院血液病中心(新疆维吾尔自治区血液病研究所),新疆 乌鲁木齐 830054

雷帕霉素 γδT细胞 MEC-1 mTOR 白细胞介素(IL)-17 细胞增殖 细胞活性 细胞毒活性

国家自然科学基金资助项目国家自然科学基金资助项目新疆维吾尔自治区科技计划项目

82160034818600332022D14008

2024

生物医学工程与临床
天津市生物医学工程学会,天津市第三中心医院

生物医学工程与临床

CSTPCD
影响因子:0.462
ISSN:1009-7090
年,卷(期):2024.28(1)
  • 29